Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03652441 |
Title | Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma |
Recruitment | Unknown status |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University of Cologne |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | DEU |